265 results on '"Sussman, Gordon L"'
Search Results
2. Diphenhydramine: Time to Move on?
3. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials
4. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
5. Occupational Allergies to Cannabis
6. Garadacimab for the prevention of hereditary angioedema attacks: a plain language summary of the VANGUARD study
7. Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet
8. SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration
9. Pathophysiology of bradykinin and histamine mediated angioedema
10. Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
11. Relevance of lipid transfer protein to Cannabis sensitization in North America
12. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial
13. Garadacimab, a Factor XIIa Inhibitor for Hereditary Angioedema Prevention (VANGUARD Study)
14. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials
15. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria
16. Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial
17. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
18. Prevention of Immunoglobulin E Sensitization to Latex in Health Care Workers After Reduction of Antigen Exposures
19. A 63-year-old man with chronic spontaneous urticaria
20. Utilisation appropriee des antihistaminiques
21. How to use antihistamines
22. Latex Allergy: Epidemiological Study of 1351 Hospital Workers
23. Evaluating chronic urticaria patients for allergies, infections, or autoimmune disorders
24. Cannabis: An Emerging Occupational Allergen?
25. Lipid transfer protein from Hevea brasiliensis (Hev b 12), a cross-reactive latex protein
26. Allergens and natural rubber proteins
27. Mutational analysis of the IgE epitopes in the latex allergen Hev b 5
28. The spectrum of IgE-mediated responses to latex
29. Molecular and immunologic characterization of new isoforms of the Hevea brasiliensis latex allergen Hev b 7: Evidence of no cross-reactivity between Hev b 7 isoforms and potato patatin and proteins from avocado and banana
30. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis
31. Human IgE-binding epitopes of the latex allergen Hev b 5
32. Update on the Hamilton, Ontario latex sensitization study
33. Incidence of latex sensitization among latex glove users
34. Latex allergy: historical perspective
35. Latex sensitivity in dental students and staff: A cross-sectional study
36. Safe Use of Latex Rubber
37. Allergy to Latex Rubber
38. Specific IgE response to purified and recombinant allergens in latex allergy
39. Omalizumab: A Potential Therapy Option for Allergic Bronchopulmonary Aspergillosis (ABPA) in Asthma Patients
40. House Dust Mite isn't Selfish When it Comes to Shellfish
41. Safety of latex prick skin testing in allergic patients
42. Cannabis: An Emerging Occupational Allergen?
43. Effect of varying doses of epicutaneous immunotherapy vs placebo on reaction to peanut protein exposure among patients with peanut sensitivity: A randomized clinical trial
44. Relevance of lipid transfer protein to Cannabissensitization in North America
45. Autoinflammatory Disease: Presenting As Urticaria
46. Chronic Spontaneous Urticaria; Centres' of Excellence
47. Impact of Solicitation of Adverse Events on the Safety Profile of 12 SQ House Dust Mite Sublingual Immunotherapy Tablet
48. Consistent Efficacy and Safety of 12 SQ House Dust Mite Sublingual Immunotherapy Tablet Among Subgroups with Allergic Rhinoconjunctivitis
49. Patient demographics and real-world use of omalizumab for the treatment of chronic spontaneous/idiopathic urticaria in Canada
50. Efficacy and Safety of Long-Term Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin® peanut: Results of the Two-Year Extension of the Vipes Phase IIb Clinical Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.